Seleccione su idioma
CAR-γδT cells offer powerful antitumor activity, high safety, enhanced tumor infiltration, and strong potential as next-generation allogeneic immunotherapies.
CAR-NK cells represent the next evolution in cancer cell therapy. Discover their advantages over CAR-T cells, their proven efficacy in hematologic and solid tumors, and the clinical breakthroughs shaping the future of immunotherapy.
CAR-Macrophages are redefining cancer immunotherapy by targeting solid tumors, remodeling the tumor microenvironment, and boosting immune response.
La Unidad del Dolor de Vithas Valencia aplica radiofrecuencia para aliviar el dolor lumbar por artrosis, mejorando movilidad y calidad de vida.
Discover how immunotherapy and CYTAC technology are revolutionizing cancer treatment. Learn how these therapies merge general mechanisms with personalized immune responses to fight disease.
Descubre cómo la ergonomía, el movimiento y el descanso previenen el dolor laboral crónico y mejoran tu salud y productividad diaria.
The Journal of Public Health and Medicine proudly welcomes Dr. Adrian Pablo Hunis to its Editorial Board. His expertise in public health and medicine will enhance the journal’s mission to promote high-quality, impactful scientific research and publications.
Página 2 de 7
